TODAYResults: Alkermes; Apple; Biogen Idec; TNT Express.Indicators: US pending home sales (Sep); German retail sales (Sep); Japanese unemployment rate(...)
When Alkermes acquired Elan’s drug technology business in Athlone in a $960 million buyout two years ago, everyone knew what it was after – or at leas(...)
Irish biopharma business Alkermes yesterday hosted a gathering of US investors in their only Irish stop on the European tour.The group of investment f(...)
A US bidder swoops for Elan triggering speculation that more Irish-domiciled drug companies may find themselves in the crosshairs of acquisitive forei(...)
Alkermes, the company that acquired Elan Drug Technologies, yesterday reported “robust” results for what it called a “remarkable year”.
Alkermes, the US company that acquired Elan’s drug manufacturing business in Athlone, announced today that it will cut almost a third of the wo(...)
Irish biopharma group Elan has closed a deal to transfer ownership of its multiple sclerosis drug Tysabri to US partner Biogen Idec in return f(...)
Browse by Publication Date